|
Gonzalez, Hernan E; Gujrati, Manu; Frederick, Mitchell et al. (2003) Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:754-9
|
|
Nakashima, T; Sun, S Y; Lotan, R et al. (2001) All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma. Laryngoscope 111:1459-64
|
|
Nakashima, T; Clayman, G L (2000) Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 126:957-61
|
|
Nakashima, T; Pak, S C; Silverman, G A et al. (2000) Genomic cloning, mapping, structure and promoter analysis of HEADPIN, a serpin which is down-regulated in head and neck cancer cells. Biochim Biophys Acta 1492:441-6
|
|
Henderson, Y C; Clayman, G L (2000) An effective method for removing ribosomal RNA during mRNA purification. Methods Cell Sci 22:253-5
|
|
Henderson, Y C; Breau, R L; Liu, T J et al. (2000) Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus. Head Neck 22:347-54
|
|
Nakashima, T; Hudson, J M; Clayman, G L (2000) Antisense inhibition of vascular endothelial growth factor in human head and neck squamous cell carcinoma. Head Neck 22:483-8
|
|
Hong, F D; Clayman, G L (2000) Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. Cancer Res 60:6551-6
|
|
Frederick, M J; Henderson, Y; Xu, X et al. (2000) In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol 156:1937-50
|
|
Clayman, G L (2000) The current status of gene therapy. Semin Oncol 27:39-43
|
Showing the most recent 10 out of 17 publications
